शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSELink Pharma Chem Ltd· Chemicals & PetrochemicalsHighNeutral
Announced Thu, 21 May, 2026 · 19:44 IST

Audited Financial Results of the Company for the quarter and year ended March 31, 2026 along with Statutory Auditor''s Report thereon.

Net loss reportedRevenue growth above 20%Negative operating cash flowResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.9%Reaction day
₹29.88
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-3.0% vs market
Commodity Chemicals peers, median of 52sector-0.3%-2.6% vs sector

On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 2.6 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.9+0.1-3.0-0.3-2.6
Next day
-6.3+1.7-8.0+0.1-6.4
2d
-6.3+2.4-8.7+0.9-7.2
3d
-6.1+2.4-8.5+0.9-7.0
4d
-6.3+1.7-8.0-0.0-6.3
5d
-9.6+0.6-10.2-3.3-6.3
1w
-6.0+1.9-7.9-0.8-5.2
15d
-8.8+4.9-13.7-1.6-7.2
1m
-9.6+8.9-18.6-0.5-9.2
2m
—+7.5—-4.0—
3m
-6.3+13.6-19.9-1.3-5.0
UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 52Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Link Pharma Chem Ltd reported a turnaround from loss to profit for FY2026. Total income increased to Rs 2,763.49 Lakhs from Rs 2,561.99 Lakhs in the previous year, representing approximately 7.86% revenue growth. The company swung from a loss of Rs 102.73 Lakhs in FY2025 to a profit of Rs 7.69 Lakhs in FY2026. However, the Q4 March 2026 quarter showed a loss of Rs 40.86 Lakhs despite revenue of Rs 658.88 Lakhs. The auditors issued an unmodified opinion with no qualifications. Cash flow from operations remained positive at Rs 214.65 Lakhs, and the company also reported other comprehensive income of Rs 4.96 Lakhs.

Likely market impact

The company returned to profitability after two consecutive loss-making years, which is a positive sign. However, the profit margin remains extremely thin (0.28% PAT margin) and the Q4 loss raises concerns about the sustainability of this recovery. Shareholders should monitor whether this is a genuine turnaround or a one-time improvement.